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Kindler syndrome (KS) is a rare autosomal recessive disorder characterized by skin blistering in childhood
followed by photosensitivity and progressive poikiloderma. Most cases of KS result from mutations in the
KIND1 gene encoding kindlin-1, a component of focal adhesions in keratinocytes. Here, we report novel and
recurrent KIND1 gene mutations in nine unrelated Italian KS individuals. A novel genomic deletion of
approximately 3.9 kb was identified in four patients originating from the same Italian region. This mutation
deletes exons 10 and 11 from the KIND1 mRNA leading to a truncated kindlin-1. The deletion breakpoint was
embedded in AluSx repeats, specifically in identical 30-bp sequences, suggesting Alu-mediated homologous
recombination as the pathogenic mechanism. KIND1 haplotype analysis demonstrated that patients with this
large deletion were ancestrally related. Five additional mutations were disclosed, two of which were novel. To
date, four recurrent mutations have been identified in Italian patients accounting for approximatelyB75% of KS
alleles in this population. The abundance of repetitive elements in intronic regions of KIND1, together with the
identification of a large deletion, suggests that genomic rearrangements could be responsible for a significant
proportion of KS cases. This finding has implications for optimal KIND1 mutational screening in KS individuals.
Journal of Investigative Dermatology (2006) 126, 1776–1783. doi:10.1038/sj.jid.5700339; published online 4 May 2006
INTRODUCTION
Although Kindler syndrome (KS, OMIM 173650) was first
described over 50 years ago (Kindler, 1954), the underlying
molecular pathology was only established in 2003 (Jobard
et al., 2003; Siegel et al., 2003). The disorder results from
loss-of-function mutations on both alleles of the KIND1 gene
that encodes the protein kindlin-1 (also known as kindlerin).
The clinical characteristics of KS include congenital skin
blistering and mild photosensitivity, which improve with age,
and generalized progressive poikiloderma with extensive
atrophy. Other features include webbing of the fingers,
palmoplantar keratoderma, nail abnormalities, involvement
of the oral cavity, and of esophageal and urethral mucosae.
Squamous cell carcinoma of the skin and mucous mem-
branes has been reported as a complication of KS (Ashton,
2004).
The KIND1 gene, mapped to chromosome 20p12.3, spans
48.5 kb of genomic DNA and consists of 15 exons. However,
the physiological functions of the gene product, kindlin-1, are
not yet fully understood. Kindlin-1 exhibits N-terminal
homology to filopodin, a Dictyostelium talin homologue
(Siegel et al., 2003; White and McLean, 2005) and C-terminal
homology to talin. It also possesses two regions of homology
with the four-point one ezrin radixin moesin domain, which
is shared by several other proteins involved in cytoskeleton
attachment to the plasma membrane. The bipartite four-point
one ezrin radixin moesin domain is interrupted by a
pleckstrin homology domain. Pleckstrin homology domains
mediate associations with phosphatidylinositol phospholipids
in the plasma membrane and are a feature of cytoskeleton
associated and/or cell-signalling molecules. In vitro studies
demonstrated that in cultured epithelial cells kindlin-1
associates with vinculin and actin at focal adhesions (Siegel
et al., 2003). Furthermore, kindlin-1 forms complexes with
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the cytoplasmic domains of integrin b subunits, and its ex-
pression is transforming growth factor-b dependent (Kloeker
et al., 2004). These observations implicate kindlin-1 in cell
adhesion and other integrin-mediated cellular processes
(Lanschuetzer et al., 2003), but more studies on normal and
mutated kindlin-1 are required to elucidate all functions and
binding partners of this protein.
Thus far, approximately 20 different KIND1 mutations have
been reported in KS (Ashton, 2004; Fassihi et al., 2005;
Sethuraman et al., 2005). These include nonsense, frameshift
and splice site mutations, and evidence for some recurrent
and founder mutant alleles has been published. Specifically,
the mutations p.R271X and p.R288X have been described in
individuals with KS from different ethnic backgrounds and
with different KIND1 haplotypes, whereas propagation of the
mutations c.676_677insC, IVS7-1G4A, p.E304X, and
p.W616X have been documented in the Pakistani, Italian,
Caucasian European, and Omani populations, respectively
(Ashton et al., 2004; Has and Bruckner-Tuderman, 2004). In
this study, we have investigated the gene pathology of KS in
nine further unrelated Italian individuals and disclosed new
and recurrent mutations in this population, including, for the
first time, a large internal deletion resulting from Alu-mediated
homologous recombination. These findings have implications
for understanding the molecular basis of KS and the design of
mutation detection strategies in the KIND1 gene.
RESULTS
Clinical and skin biopsy features of Italian subjects with KS
Nine unrelated patients with KS from different regions of Italy
were studied (Table 1). Consanguinity was reported in three
families. Acral poikiloderma with skin atrophy and dyschro-
mia (Figure 1a) were the main clinical features in adult
patients, while trauma- or sun-induced bullous skin lesions
were observed in the younger patients. The 6-year-old patient
4 had acral blistering present since birth and was initially
diagnosed as having epidermolysis bullosa. Recently, how-
ever, pronounced skin atrophy on the dorsal aspects of her
hands and feet and webbing of the fingers (Figure 1b) gave
the clue to the actual diagnosis of KS. Except for patient 4, all
showed some degree of oral involvement. Ectropion was
present in five patients and digit webbing in six. In patient 3,
esophageal dilatation was performed at the age of 23 years to
release strictures. The 52-year-old patient 6 was treated for a
squamous cell carcinoma of the lower lip. Ultrastructurally,
reduplication of the lamina densa was detected in all patients
examined (Figure 1c), while hemidesmosomes and anchoring
fibrils appeared morphologically normal. Microdetachments
within the lamina lucida were also observed in two patients
(Figure 1d). Skin biopsies from patients 3–5, 7, and 8 were
studied by immunofluorescence microscopy with antibodies
to proteins involved in dermal–epidermal adhesion. In all
cases, there was thickened and interrupted basement
membrane labelling at the dermal–epidermal junction (Figure
1f and h). The abnormal staining pattern was prominent for
collagens IV, VII (Figure 1f), and XVII (Figure 1h), as well as
laminin 5, while linear staining for a6b4 integrin was similar
to control.
Characterization of a 3.9 kb deletion mutation in four unrelated
families
Using the mutation detection strategy of sequencing PCR
products amplified from genomic DNA (for details see Siegel
et al., 2003), no KIND1 mutations were detected in patients
1–3 and their parents. However, DNA samples from these
patients repeatedly failed to yield PCR amplification products
for exons 10 and 11. Therefore, we assumed the presence of a
genomic deletion spanning exons 10–11. In patient 4 and her
mother, a heterozygous mutation c.910G4T (p.E304X), was
disclosed, but the second, paternal mutation, could not be
identified. No heterozygous single nucleotide polymorphisms
were present in exons 10 and 11 and their flanking intronic
regions. As a result of the homozygosity in this region, an
identical single nucleotide polymorphism haplotype with
patients 1–3 (see below) and the fact that families 1–3 came
from Calabria, we also tested family 4 for the same putative
deletion of exons 10 and 11.
To confirm the suspected deletion, quantitative real-time
PCR was performed using two primer pairs for each of exon
10 or exon 11 (Table S1). Calculation of the relative copy
number of KIND1 gene exons 10 and 11 yielded values
consistent with (i) the absence of these exons in both alleles
of patient 3 (ratio¼ 0), (ii) the absence of the target exons in
one allele of parents of patient 3, patient 4 and her father
(ratioD0.5), and (iii) the presence of the target exons in both
alleles of the mother of patient 4 (ratioD1) (Figure 2a).
Results similar to those of family 3 were obtained for families
1 and 2. Additional quantitative PCR assays were performed
with primer pairs positioned in the middle of intron 9 (qi9F
and R) and in the middle of intron 11 (qi11F and R). The
resulting amplification plots were consistent with homozygo-
sity for the two KIND1 target amplicons in all families and
allowed us to circumscribe the deleted interval (not shown).
In order to identify the deletion breakpoints, primers qi9F
and qi11R were then used to amplify across the deletion
(Figure 2b, upper panel). A fragment of B1.5 kb, instead of
the B5.5 kb wild-type PCR product, was obtained with
template DNA from affected patients and healthy carrier
family members, while it could not be amplified using the
DNA of the mother of patient 4 and a control subject (Figure
2b, middle panel). Sequencing of the B1.5 kb fragments
resulted in the identification of the 50 and 30 breakpoints
within introns 9 and 11 (g.70250_74168del with respect to
GenBank AL118505, reverse complemented strand; Figure
2b, lower panel), and demonstrated that the four families
carried the same deletion of 3,919 bp.
To establish an easy and rapid test for detecting this
homozygous or heterozygous mutation, we developed a PCR
reaction that makes use of three primers, two of them being
positioned outside the deletion (primers a and c), and the
third one placed within the deletion (primer b) (Figure 3a,
upper panel). In the presence of a normal allele, an 835-bp
fragment is generated by using primers b and c, whereas in
the presence of the deleted allele a 362-bp product is
amplified with primers a and c. As shown in Figure 3a (lower
panel), this diagnostic PCR generated a single band of 362 bp
in patients 1–3, whereas two bands of 362 and 835 bp were
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observed in patient 4 and several healthy carriers belonging
to the patients’ families. Finally, a solitary band of 835 bp was
observed in healthy controls, indicating absence of the
deletion. Using this assay, the deletion mutation was not
detected in any allele of 102 control Italian individuals.
The consequences of the genomic deletion on KIND1
expression were also investigated by reverse transcriptase
(RT)-PCR analysis of the mRNA purified from cultured
keratinocytes of patient 1 (homozygous for the
g.70250_74168del mutation), using primers spanning exons
5–13. With the patient’s sample, a single band of 796 bp was
generated, whereas a wild-type fragment of 1,028 bp was
evident in a control sample (Figure 3b). Sequencing of the
796-bp cDNA fragment showed the deletion of exons 10 and
11 which introduces a frameshift starting with codon 381 and
terminating with a premature termination of translation 36
codons downstream. This predicts elimination of the entire
C-terminal four-point one ezrin radixin moesin domain of
kindlin-1 (Figure 3b).
Haplotype analysis of intragenic single nucleotide poly-
morphisms (for details see Ashton et al., 2004) showed that
the 3.9 kb deletion occurred on the same genetic background
in all patients. We extended the analysis of the haplotype
found to be associated with the recurrent mutation p.E304X
(Ashton et al., 2004) by analyzing patient 4 and her family
and an additional European patient with the homozygous
mutation p.E304X (Has and Bruckner-Tuderman, 2004); they
also had the same ancestral KIND1 allele (Table S2).
Novel and recurrent point mutations in KIND1
Sequencing of all KIND1 exons led to the identification of a
homozygous mutation in five other individuals (Table 1). Two
of these mutations (IVS13-1G4A and c.95_96delGA
(p.R32fsX63)) were novel and not found in 102 control
Italian individuals. Mutations IVS13-1G4A led to aberrant
splicing of exon 14, as demonstrated by RT-PCR analysis of
total RNA purified from cultured keratinocytes of patient 5
(not shown). In patients 7 and 8, the same homozygous single
nucleotide deletion, c.1161delA (p.A388fsX14), was identi-
fied within exon 10. This mutation has been previously
documented in a Caucasian patient from the UK (Ashton
et al., 2004). Haplotype analysis of patients 7 and 8 showed
that the mutation c.1161delA is associated with a common
genetic background (not shown). In patient 9, a homozygous
deletion mutation, c.373delT (p.C125fsX4), was disclosed.
This mutation has been previously described in an Italian
patient (Siegel et al., 2003).
DISCUSSION
This report has identified the molecular basis of KS in nine
Italian individuals with KS and, taken together with other
published reports, KIND1 gene mutations have now been
identified in 14 subjects from 13 Italian families (Siegel et al.,
2003; Ashton et al., 2004). Interestingly, in a number of
families with KS reported in the literature, mutations in
KIND1 could not be disclosed, in spite of homozygosity by
descent at the KIND1 locus (Jobard et al., 2003; Siegel et al.,
Table 1. Mutations and major clinical features of Italian individuals with Kindler syndrome
Patient
Age/
sex
Consan-
guinity
Geographic
origin Mutations1
Atrophy of
the dorsum
of hand and
feet/webbing
Poikilo-
derma
Photo-
sensitivity
Trauma- and
sun-induced
blistering
Tumor
development
1 41/F No Southern Italy (Calabria) g.70250_74168del/g.70250_74168del +/ + +  
2 16/F Yes Southern Italy (Calabria) g.70250_74168del/g.70250_74168del +/ + + + 
3 25/F Yes Southern Italy (Calabria) g.70250_74168del/g.70250_74168del +/+ + +/  
4 6/F No Father from Southern Italy (Calabria) g.70250_74168del/c.910G4T +/+  + + 
5 18/F Yes Northern Italy (Emilia Romagna) IVS13-1G4A/IVS13-1G4A +/ + + + 
6 52/F No Sardinia c.95_96delGA/c.95_96delGA +/+ + +  +
7 13/M No Central Italy (Tuscany) c.1161delA/c.1161delA +/+ + + + 
8 23/M No Central Italy (Marche) c.1161delA/c.1161delA +/+ + +  
9 42/M No Central Italy (Lazio) c.373delT/c.373delT +/+ + +  
Previously reported Italian KS individuals
10 NA NA NA c.373delT/c.373delT2 NA NA NA NA NA
11 48/M Yes Central Italy (Lazio) IVS7-1G4A/IVS7-1G4A3 +/+ + +  +
124 36/M No Central Italy (Lazio) IVS7-1G4A/IVS7-1G4A3 +/ + +  
134 38/M No Central Italy (Lazio) IVS7-1G4A/IVS7-1G4A3 +/+ + +  
145 21/M Yes North Africa c.1714_1715insA/c.1714_1715insA3,5 +/+ + +/ + 
F, females; M, males; NA, data not available.
1Mutations are indicated on the basis of the nucleotide change in the cDNA (GenBank AY137240) or genomic (GenBank AL118505, reverse complemented
strand) sequence of KIND1.
2Siegel et al. (2003).
3Ashton et al. (2004).
4These patients are siblings.
5Mutation observed in this patient was also detected in a North African Arab reported in Jobard et al., 2003.
1778 Journal of Investigative Dermatology (2006), Volume 126
C Has et al.
Molecular Basis of Kindler Syndrome in Italy
2003). This suggested that the commonly used mutation-
detection strategies based on screening or sequencing of
exons and intron–exon boundaries in genomic DNA fail to
detect a certain number and type of mutations. Indeed, using
established protocols we found mutations in only six of nine
patients in this study.
Quantitative PCR and long-range PCR techniques were
employed to search for larger rearrangements in genomic
DNA of four patients. These techniques led to the identifica-
tion of the first large deletion mutation in the KIND1 gene.
Quantitative PCR was shown to be a useful method to detect
the deletion in the heterozygous state and to narrow down
the deleted interval. In addition, a straightforward and
accurate genomic DNA-based PCR test for routine diagnostic
detection of the deletion was developed. RT-PCR and
sequence analysis of the resulting cDNA fragment confirmed
that the mutant g.70250_74168del mRNA variant contains an
aberrant splicing junction between exons 9 and 12 and
terminates translation 116 nucleotides upstream of splicing-
generated exons 12–13 junction. Notably, nonsense-
mediated mRNA decay in mammals downregulates spliced
mRNA that harbors premature termination codon followed by
an exon–exon junction located more than 50–55 nucleotides
downstream (Inoue et al., 2004; Maquat, 2005). Therefore, it
is expected that kindlin-1 nonsense-mediated mRNA decay
occurs in cells bearing the g.70250_74168del mutation. The
visualization of a detectable amount of aberrant mRNA by
RT-PCR may be explained by the ability of this technique to
amplify unstable mRNA, even if strongly reduced and almost
undetectable by Northern blot analysis (Aberdam et al.,
1994; Baudoin et al., 1994). Although the synthesis of a
residual amount of polypeptide from mutant mRNA cannot
be formally excluded, this abnormal protein is predicted to be
nonfunctional. Indeed, the deletion of 232 nucleotides
corresponding to exons 10 and 11 results in the elimination
of 77 amino acids within the pleckstrin homology domain of
kindlin-1 and generates a frameshift leading to truncation of
the entire C-terminal four-point one ezrin radixin moesin
domain. Both these domains are believed to be critical for the
function of kindlin-1.
Computational analysis of the KIND1 gene was performed
to investigate the mechanism underlying this large deletion.
NCBI Map Viewer inspection revealed that introns 9 and 11
contain 15 and five repetitive sequence elements, respec-
tively, accounting for 48 and 59% of the intronic length.
These sequences comprise several members of distinct
subfamilies of Alu repeats as well as other interspersed
repetitive elements (Figure 4a) (Batzer and Deininger, 2002).
Mutation g.70250_74168del in KIND1 is likely to be the
result of homologous unequal recombination as the se-
quences spanning the junction region show high homology
(83%) with Alu-repetitive elements. In particular, a recombi-
nation event in this deletion appears to have occurred
between an almost uninterrupted 50 AluSx repeat located
within intron 9 and another AluSx repeat within intron
11 near the 30 breakpoint (almost completely deleted as a
a b c
d
e f
hg
*
*
*
*
Figure 1. Clinical and skin biopsy findings in KS. (a) In patient 3, poikiloderma is evident on the neck and non-sun exposed skin behind the ear.
(b) Cigarette paper-like atrophy is present on the dorsal aspect of the right hand of patient 4. (c) Ultrastructural analysis of KS skin showing reduplication of
the lamina densa (red arrows) in patient 7, and (d) microdetachments (asterisks) within the lamina lucida in patient 8. (e) Linear labelling at the dermal
epidermal junction for collagen VII in normal skin. (f) Markedly thickened, reticular, and patchy pattern of collagen VII labelling in patient 7. (g) Indirect
immunofluorescence with antibodies to collagen XVII produced a linear staining in normal skin, but (h) an interrupted pattern in the skin of patient 4.
Bars¼ (c and d) 0.85mm and (e–h) 20mm.
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result of the recombination). The precise site of the
recombination event has been narrowed to a 30-bp
sequence, (gcactccagcctgggtgacagagcaagact), which shows
100% homology in the two AluSx-repeat regions involved
(Figure 4b) (Deininger and Batzer, 1999; Ringpfeil et al.,
2001).
We have calculated that 52% of all noncoding regions of
KIND1 are represented by repetitive sequences, and almost
half of these repeats are Alu elements (24% of all intronic
sequences). Of note, the two AluSx elements involved in the
deletion presented here harbor two common 26-bp core
sequences, one of which is present near the crossover site.
This 26-bp core sequence has been proposed to be highly
recombinogenic because it lies frequently at, or close to, the
sites of recombination and also in view of its structural
similarity with recombinational hotspot sequence present in
E. coli (Figure 4b) (Ru¨diger et al., 1995; Le Saux et al., 2001).
Eleven out of 16 AluSx repeats dispersed along the intronic
sequences of KIND1 contain such 26-bp core sequences that
are more than 95% conserved. Our findings support the
hypothesis that DNA rearrangements might account for a
significant number of the KS cases in whom pathogenic
mutations could not be detected using previously published
genomic PCR amplification of KIND1 exons (Jobard et al.,
2003; Siegel et al., 2003) and suggest that screening for
KIND1 rearrangements should be performed in these
patients.
To date, four recurrent KIND1 mutations, comprising
g.70250_74168del (23.8% of the mutated alleles)
c.1161delA (19.0%) IVS7-1G4A (14.3%), and c.373delT
(19.0%) have been identified in Italian patients with KS
(Table 1). Each of these has been detected in families from
similar parts of Italy, and haplotype analysis of highly
polymorphic single nucleotide polymorphisms within the
coding region of KIND1 in the patients carrying these
mutations indicates a common ancestral origin for the
corresponding mutant allele. In the case of extremely rare
autosomal recessive genetic diseases, such as KS, most alleles
from patients originating from a restricted geographical area
will be identical-by-descent due to genetic drift and hidden
inbreeding. Indeed, Italian patients with KS are all, except
one, homozygous for the causative mutation. Homozygosity
for more than one recurrent mutation is the result of distinct
founder effects following the occurrence or the introduction
of different KIND1 mutations in various regions of Italy.
Altogether, the frequent mutations account for B75% of the
KS alleles in the Italian population and therefore, for optimal
mutation detection, new KS patients should first be screened
for the presence of these mutations. Interestingly, the
mutation c.1161delA have been also detected in a British
patient and the p.E304X mutation has been identified in a
Swiss, an Austrian, and three British patients (Lanschuetzer
et al., 2003; Ashton et al., 2004; Has and Bruckner-
Tuderman, 2004), suggesting propagation of ancestral mutant
alleles in the Caucasian European population due to both
genetic drift and geographic migration of ancient populations
across the Alps.
Assessment of skin biopsies by immunofluorescence
microscopy and transmission electron microscopy of the
dermal–epidermal junction can give good clues to
the diagnosis of KS (Fassihi et al., 2005), but optimization
of mutation detection strategies requires knowledge of the
molecular basis of KS within particular countries or
ethnic groups. As such, the findings in our study help
refine mutation detection strategies for patients with this
genodermatosis.
MATERIALS AND METHODS
Patients and biological materials
Nine Italian unrelated KS patients were studied (Table 1).
The diagnosis was based on physical examination and clinical
history. Skin biopsies were obtained from six patients (subjects
1, 3–5, 7, 8) and processed for ultrastructural examination
and/or immunofluorescence analysis with antibodies to basement
membrane zone (Hammami-Hauasli et al., 1998; Terracina et al.,
1998; Castiglia et al., 2001). In three patients, a skin biopsy
specimen was also processed for keratinocyte culture. Keratinocytes
were cultivated on a feeder layer of lethally irradiated 3T3-J2
murine fibroblasts (a gift from H. Green, Harvard Medical School,
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Figure 2. Characterization of the 3.9 kb deletion (g.70250_74168del) in
KIND1. (a) Relative copy number of KIND1 gene exons 10 and 11 in the
genomic DNA of patients 3 and 4 (P3, P4) and their parents (FP3, MP3, FP4,
and MP4) measured by quantitative real-time PCR. (b, upper panel) Schematic
representation of the KIND1 genomic region spanning exons 9–12. The 3.9 kb
deletion mutation is depicted by the dashed line. Primers qi9F and qi11R
were used to amplify a 5.5 kb region (hashed bar). (b, middle panel) A PCR
product of B1.5 kb instead of the expected B5.5 kb amplicon was obtained
with genomic DNA from patients 1 to 4 (P1–P4) and patients’ parents (MP1,
MP2, MP3, FP1, FP3, and FP4). Mw, 100 bp DNA ladder. (b, lower panel)
Sequencing of the 1.5 kb-PCR products showed identical deletion breakpoints
within introns 9 and 11. The precise breakpoint lies somewhere in the 30 bp
between the 50 variant base in intron 9 and the 30 variant base in intron 11
(asterisks).
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Boston, MA), as described (Zambruno et al., 1995). This study
was conducted in accordance to the Declaration of Helsinki
Principles; skin biopsies and blood samples were obtained from all
patients and their parents after written informed consent and
approval by the ethical committees of IDI-IRCCS, St Thomas’
Hospital London, and of the University of Freiburg. Genomic DNA
was extracted from blood using a standard kit (Qiagen, Hilden,
Germany).
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Figure 4. Abundance of repetitive elements within introns 9 and 11 of KIND1. (a) Schematic representation of the genomic region spanning exons 9–12.
Orientation and type of the repetitive sequence elements comprised in this region are indicated by arrowheads, the size of which is proportional to the
length of the corresponding repeat. The two AluSx sequences involved in the 3.9 kb deletion are indicated by gray arrowheads. (b) Sequence alignment
between the AluSx repeats containing the deletion breakpoints. The sequences show 83% identity. The 30-bp sequence which identifies the precise site
of the crossover event is highlighted by the gray box and the two 26-bp core sequences are depicted between the square brackets. The boldface type
represents the sequence of the KIND1 mutated allele that results from the recombination event.
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Figure 3. Verification of the g.70250_74168del mutation in the affected families and mutation consequences at mRNA level. (a, upper panel) PCR-based
diagnostic test for rapid screening of the deletion g.70250_74168del using primers a–c. Shaded region represents the 3.9 kb deletion. (a, lower panel) A
single band of 362 bp was visualized in patients 1–3 (P1–P3), whereas two bands of 362 and 835 bp were observed in patient 4 (P4) and in healthy carriers from
these families (MP1, FP1, MP2, MP3, FP3, and FP4). The mother of patient 4 (MP4) and two unaffected controls (C1 and C2) generated a 835 bp band
(lanes 11–13). Mw, 100 bp DNA ladder. (b) RT-PCR analysis of total RNA from patient 1 (P1) resulted in a unique PCR product of 796 bp instead of the normal
product of 1,028 bp amplified from control cells (C). The 796-bp fragment corresponded to an aberrant out-of-frame transcript carrying the deletion of exon
10 and 11 (232 bp). Mw, 100 bp DNA ladder. A schematic representation of kindlin-1 structure with mutation consequences at protein level is also shown.
PTC, premature termination codon. FERM, four-point one ezrin radixin moesin domain; PH, pleckstrin homology domain.
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Mutation detection strategy
PCR amplification of the KIND1 gene was performed on genomic
DNA (100 ng) as template and using intronic primers specific for
each KIND1 exon, as detailed elsewhere (Jobard et al., 2003; Ashton
et al., 2004). PCR products were directly sequenced in both
orientations in an ABI 3100 genetic analyzer (ABI, Darmstadt,
Germany). Each mutation was confirmed by re-sequencing the PCR
product obtained from a second amplification reaction.
Quantitative real-time PCR
Detection of the large genomic deletion was carried out with
quantitative PCR and SYBR-Green I detection method, as described
(Boehm et al., 2004; Borozdin et al., 2004). Primers for generation of
small amplicons corresponding to exons 10 and 11 were designed
with the software http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi. Amplicons corresponding to exon 4 (hsall 4F/R) of the
SALL4 gene were used as an internal reference. For real-time
detection, the ABI Prism 7900 system and 384-well plates (both from
PE Applied Biosystems, Norwalk, CT) were used. Reactions
contained 0.25 mM of each primer and 5ml of QuantiTect SYBRs
Green PCR Master Mix (Qiagen, Hilden, Germany) in a final volume
of 10 ml. Each run included samples of serially diluted control DNA
(40, 20, 10, and 5 ng) for the generation of standard curves for each
primer pair, and genomic DNA samples from patients, parents and
controls (25 ng). The PCR program consisted of 501C for 2 minutes,
951C for 15 minutes, and 40 cycles of 941C for 15 seconds, 541C/
601C for 15 seconds, and 721C for 1 minute. To verify the specificity
of the primers, melting curve analysis of the amplicons was
performed and the results were evaluated as previously described
(Borozdin et al., 2004). Sequence of primers and amplification
conditions used for quantitative real-time PCR are given in Table S1.
Cloning and sequencing of the junction fragments
The forward primer qi9F and the reverse primer qi11R (Table S1)
were used for amplification of the genomic region spanning exons
10 and 11. The PCR reaction contained 0.9 mg of genomic DNA,
1 PCR buffer, 2.5 mM MgCl2, 250mM of each deoxynucleoside
triphosphate, 2.5 mM of each primer, and 2.5 U of TaKaRa LA Taq
enzyme (TAKARA Bio Inc., Otsu, Japan) in a final volume of 50 ml.
An initial denaturation step at 941C for 3 minutes was followed by 30
cycles of 941C for 15 seconds, 601C for 30 seconds, and 721C for
7 minutes, and a final elongation step at 721C for 10 minutes. The
PCR product was subcloned with the TOPO cloning kit for
sequencing (Invitrogen, San Diego, CA). Plasmid DNA was isolated
from bacterial colonies by routine methods and sequenced using T7,
T3 primers and the primer seqKSIntron9: 50-cagtctagccaacatgatga-30.
The KIND1 sequence (GenBank accession number NT_011387)
surrounding the breakpoint was masked for repeats with the online
software BCM Search Launcher (http://searchlauncher.bcm.tmc.edu/
seq-search/alignment.html) and AluSx elements involved in the
deletion were aligned.
PCR-based detection of the 3.9-kb deletion in genomic DNA
After the junction fragment had been sequenced and the deletion
breakpoints precisely identified, primers a–c (Table S1) were used for
detection of the deletion mutation in KS families. These three primers
were used in a single PCR reaction at the following concentration:
primer a, 0.25mM, primer b, 1.5 mM, and primer c, 2mM (annealing
temperature 601C), in a volume of 50 ml. Standard cycling conditions
were used for amplification.
RT-PCR analysis
Total RNA was purified from cultured cells using the NucleoSpins
RNA II kit (Mackerey-Nagel, Du¨ren, Germany) and converted to
cDNA using the SuperScriptTM Rnase H free reverse transcriptase
(Invitrogen) and an oligo dT as primer. PCR amplifications of the
KIND1 cDNA was carried out with primers RT12S and RT15AS
(nucleotides 1,494–2,153) spanning exons 12–15 in patient 5, and
using primers RT5S and RT13AS (nucleotides 637–1,664) spanning
exons 5–13 in patient 1 (GenBank accession number NM_017671)
(Table S1). PCR products were analyzed on 1.5% agarose gel
electrophoresis and specific bands were excised from the gel,
purified, and directly sequenced.
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